ScholarGate
Asistent

Compară metode

Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.

Criteriile de diagnostic Roma IV pentru sindromul de intestin iritabil×Chestionar scurt pentru boala inflamatorie intestinală×
DomeniuGastroenterologieGastroenterologie
FamilieProcess / pipelineProcess / pipeline
Anul apariției20162004
Autorul originalRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
TipDiagnostic CriteriaSelf-report
Sursa seminalăMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
Denumiri alternativeRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Înrudite44
RezumatThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateSet de date
  1. v1
  2. 1 Surse
  3. PUBLISHED
  1. v1
  2. 1 Surse
  3. PUBLISHED

Mergi la căutare Descarcă prezentarea

ScholarGateCompară metode: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Preluat la 2026-06-20 de pe https://scholargate.app/ro/compare